(Q37619625)

21 August 2017

Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs (English)

1 reference

immune reconstitution inflammatory syndrome

21 August 2017

0 references

0 references

0 references

1 reference

1

Anne F Luetkemeyer

1 reference

21 August 2017

10

Diane V Havlir

1 reference

21 August 2017

8

Susan Swindells

1 reference

21 August 2017

5

Prudence Ive

1 reference

21 August 2017

Michelle A Kendall

2

1 reference

21 August 2017

Mulinda Nyirenda

3

1 reference

21 August 2017

Xingye Wu

4

1 reference

21 August 2017

Constance A Benson

6

1 reference

21 August 2017

Janet W Andersen

7

1 reference

21 August 2017

Ian M Sanne

9

1 reference

21 August 2017

Johnstone Kumwenda

11

1 reference

21 August 2017

Adult AIDS Clinical Trials Group A5221 Study Team

12

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 April 2014

1 reference

Journal of Acquired Immune Deficiency Syndromes

21 August 2017

1 reference

21 August 2017

65

1 reference

21 August 2017

4

1 reference

21 August 2017

423-428

1 reference

A systematic review evaluating the impact of task shifting on access to antiretroviral therapy in sub-Saharan Africa

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3943693

Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3943693

The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3943693

Integration of antiretroviral therapy with tuberculosis treatment

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3943693

Timing of antiretroviral therapy for HIV-1 infection and tuberculosis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3943693

Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3943693

Timing of initiation of antiretroviral drugs during tuberculosis therapy

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3943693

Tuberculosis-associated immune reconstitution inflammatory syndrome and unmasking of tuberculosis by antiretroviral therapy

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3943693

Novel relationship between tuberculosis immune reconstitution inflammatory syndrome and antitubercular drug resistance

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3943693

Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3943693

Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3943693

Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3943693

10.1097/QAI.0000000000000030

1 September 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference

21 August 2017

PubMed publication ID

24226057

1 reference